Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Maravai LifeSciences Holdings, Inc. - Class A common stock
(NQ:
MRVI
)
8.885
-0.115 (-1.28%)
Streaming Delayed Price
Updated: 3:25 PM EDT, Aug 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maravai LifeSciences Holdings, Inc. - Class A common stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
This Analyst With 85% Accuracy Rate Sees Over 29% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
↗
February 27, 2023
US stocks closed lower on Friday, with the Dow Jones dropping more than 300 points during the session.
Via
Benzinga
The Latest Analyst Ratings for Maravai LifeSciences
↗
February 24, 2023
Via
Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
February 23, 2023
Gainers
Via
Benzinga
Earnings Outlook For Maravai LifeSciences
↗
February 21, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
January 30, 2023
Via
Benzinga
Where Maravai LifeSciences Stands With Analysts
↗
December 07, 2022
Via
Benzinga
6 Analysts Have This to Say About Maravai LifeSciences
↗
December 07, 2022
Via
Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
↗
February 23, 2023
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript
↗
February 23, 2023
MRVI earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
2 Healthcare Companies That Could Be Acquired Within 5 Years
↗
February 07, 2023
These stocks are also cheap buys that are down more than 60% from their highs.
Via
The Motley Fool
Where Maravai LifeSciences Stands With Analysts
↗
November 04, 2022
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter:
Via
Benzinga
Analyst Ratings for Maravai LifeSciences
↗
November 03, 2022
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter:
Via
Benzinga
Earnings Scheduled For February 22, 2023
↗
February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Via
Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
↗
February 06, 2023
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.
Via
Investor's Business Daily
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
February 01, 2023
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
3 Great Growth Stocks Down 20% or More to Buy Now
↗
January 27, 2023
These beaten-down stocks could be poised for major rebounds.
Via
The Motley Fool
3 Biopharma Stocks That Could Help Make You a Fortune
↗
January 16, 2023
All three are protected by sales of in-demand products, with more on the way.
Via
The Motley Fool
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
December 01, 2022
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
↗
January 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
↗
December 14, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
↗
November 28, 2022
These two companies are facing short-term issues that are likely to give way to long-term success.
Via
The Motley Fool
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
November 16, 2022
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
November 07, 2022
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
What 6 Analyst Ratings Have To Say About Maravai LifeSciences
↗
November 04, 2022
Within the last quarter, Maravai LifeSciences (NASDAQ:MRVI) has observed the following analyst ratings:
Via
Benzinga
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
November 03, 2022
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
November 03, 2022
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!
Via
InvestorPlace
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
↗
November 03, 2022
MRVI earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
November 02, 2022
Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
